Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, a practice that has ...

Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...

China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.

A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that ...

Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.

Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...

Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...

The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

Incessant and debilitating thoughts about food seem to be a common experience for people with obesity. Telehealth giant Ro ...

The Food and Drug Administration yesterday delivered a split decision on GSK’s blood cancer drug Blenrep, approving its use ...